Dr. Francisco Gimenez
Partner, 8VC. On 1 show, 1 appearance. The Shows tab opens the full record on each.
investorscientistfounder8vc.com/team/francisco-gimenez ↗
Francisco Gimenez is a Partner at 8VC, where he focuses on investments in Bio-IT, Health-IT, and artificial intelligence. He previously founded Catenus Science and holds a Ph.D. in Biomedical Informatics from Stanford University.
1shows
1appearances
19statements
3resolved
3supported
0contradicted
100%fully supported
Everything Dr. Francisco Gimenez said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Gimenez: More biotechs will commercialize drugs independently instead of selling
“I would say my sort of falsifiable prediction would be that we're going to start seeing more and more biotechs make drugs that they try to commercialize themselves as opposed to selling to pharma to do the commercialization.”
Gimenez: Rare cancer therapies build infrastructure to cure broader diseases
“Once we create the tools and technologies to cure those,
We have this infrastructure layer that allows us to expand it to so many others. So we cure rare cancers or cell therapies today, but we're looking and building all of the infrastructure, the manufactur…”
Gimenez: Eliminating Startup Upside Would Entrench Incumbent Pharma
“If we didn't give people upside to translate these things, there would not be a system to actually sort of commercialize these things in a sort of fast turnaround biotech ecosystem. We would be dependent, it's not like that, that innovation would go away, but …”
Gimenez: Just 100 to 200 pharma CSOs dictate which diseases get cured
“So we've got, like, on the order of, what, a hundred, maybe 200 pharmas looking to make these M&As. So it means a hundred to 200 chief scientific officers are dictating what does.”
Gimenez: Tenured academics enjoy the privilege of principle without practical trade-offs
“If you are in a tenured position in academia and you consider moving to industry, the dark side, which is always considered like the phrase that they tell you have like the privilege of principle that many other people don't, right? You don't have to make trad…”
Gimenez: Life sciences will shift from curing diseases to active human enhancement
“I think we would flip the model of what we think of in bio life sciences from amelioration of suffering, which is essentially curing diseases, to sort of improvement of, like, human condition, like this, the transhumanist might call it something like that”
Gimenez: Entrepreneurs need both humility and entitlement to succeed
“Berkeley is where I learned humility, and Stanford's where I learned entitlement which kind of angers both groups off, which is why it's the best Kind of joke, but I think it's, you need both of those to, I think, succeed in sort of entrepreneurship.”
Gimenez: Carl June cured pediatric ALL with CAR-T in 2012 breakthrough
“Carl June had his first paper come out showing that he was able to cure a pediatric oncology patient in ALL with a CAR T, which was like 30 years of effort, but that was such a big deal.”
Gimenez: Type 2 diabetes represents multiple distinct diseases based on underlying causes
“Type two diabetes is so many different diseases if we think about on a causal spectrum, as opposed to on a symptomatic endpoint spectrum.”
Gimenez: Cancer treatments should target molecular markers, not tissue origin
“There's nothing about our medicines, at least chemical medicines or biological or whatever medicines that are necessarily about the part of the body it's in besides distribution and delivery. But we're starting to rethink how we think about that and say like, …”
Gimenez: The Bayh-Dole Act Created the Modern Biotech Ecosystem
“I mean, like historically that happens because of the Bay Dole act, which is basically IP licensing and. That literally is, is why we have a biotech ecosystem in so many curative things.”
Gimenez: Governments Fund Biology on 20-to-50-Year Horizons Unlike VCs
“Governments get to think on different timescales than say venture capitalists and, you know, startups, right? A government can think on like the sort of 20, 3050 year timescale to say, let's fund exciting biology just for the, you know, Interest and pleasure o…”
Gimenez: Startups have aggressively poached academic university talent since 2017
“Startups and industry at the very least in the past five years has been some of the most insane amount of poaching away from an academic university system.”
Gimenez: Universities take 50% of academic research grant funding for overhead
“And the university takes 50% of the overhead. So if you make five million dollars, the university takes 2.5 of it.”
Gimenez: Resilience Bio raised $800M in five months
“We were able to basically put together eight hundred million dollars in the span of like, what, five months.”
Gimenez: China lockdowns severely disrupted biotech startup supply chains
“When Wuhan shut down and basically all of China shut down, it wasn't just medicines, but it was entire sort of our biotech supply chain. So many of our companies had huge delays in the sort of reagents they were able to get deals, they were able to close or wh…”
Gimenez: U.S. should not rely on foreign medical manufacturing supply chains
“Whether or not you feel discomfort around China owning it, I definitely think we should feel discomfort about not owning our own Sort of medical manufacturing supply chain.”
Gimenez: Decentralized biotech enables curing long-tail rare diseases centralized systems ignore
“If you think about that same model of like this long tail, it can be profitable if you think at a global scale, and we actually reduce the cost to actually start these kinds of innovations and distribute them to people. And think about that in the context of d…”
Gimenez: The US has first-round draft pick on global talent through immigration
“What America has that sometimes I think we forget is we have first round draft on the greatest talent in the world, right? If there is a smart person anywhere in the world, we could find a way to get them to America. So I think immigration is core to this, rig…”
One line per show, most statements first. The link opens Dr.'s full record on that show: the calibration, argument clarity, speaking style and every statement made there.
| Show | Role there | Eps | Statements | Record | |
|---|---|---|---|---|---|
 AMERICAN OPTIMISTLEDGER | Partner, 8VC | 1 | 19 | 100% 3/3 | full record on American Optimist → |